<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05063461</url>
  </required_header>
  <id_info>
    <org_study_id>00375930</org_study_id>
    <nct_id>NCT05063461</nct_id>
  </id_info>
  <brief_title>Evaluation of the Analgesia Nociception Index With Varying Remifentanil Concentrations Under Sevoflurane</brief_title>
  <official_title>Evaluation of the Analgesia Nociception Index With Varying Remifentanil Concentrations Under Sevoflurane</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Analgesia Nociception Index（ANI）which is derived by heart rate variability can be used to&#xD;
      detect noxious stimulation during propofol while changing remifentanil concentrations.The aim&#xD;
      of this study is to evaluate whether ANI can detect noxious stimulation under sevoflurane&#xD;
      with different concentrations of remifentanil.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      General anesthesia with sevoflurane and remifentanil is widely used in minor&#xD;
      surgeries.Monitoring noxious stimulation during general anesthesia is still worth further&#xD;
      studies and reaching clinical consensus.Analgesia Nociception Index can be used to detect&#xD;
      noxious stimulation during propofol while changing remifentanil concentrations.The aim of&#xD;
      this study is to evaluate whether ANI can detect noxious stimulation under sevoflurane with&#xD;
      different concentrations of remifentanil.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 25, 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Actual">October 8, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation of ANI at different analgesic levels</measure>
    <time_frame>Change from Baseline ANI that 2 minutes after applied tetanic stilumation</time_frame>
    <description>Tetanic stimulations are applied at different effect-site concentrations of remifentanil under sevoflurane. ANI is range from 0-100. Bigger number means better analgesic level. 50-70 is considered to be under adequate analgesia. Tetanic stimulation is a standard tester of nociceptive stimulus. The number of ANI will fall down if the patient is feeling pain.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Systolic Blood Pressure at different analgesic levels</measure>
    <time_frame>Change from Baseline Systolic Blood Pressure that 2 minutes after applied tetanic stilumation</time_frame>
    <description>Systolic Blood Pressure will go up if patient is feeling pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Heart Rate at different analgesic levels</measure>
    <time_frame>Change from Baseline Heart Rate that 2 minutes after applied tetanic stilumation</time_frame>
    <description>Heart Rate will go up if patient is feeling pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Bispectral Index at different analgesic levels</measure>
    <time_frame>Change from Baseline Bispectral Index that 2 minutes after applied tetanic stilumation</time_frame>
    <description>Bispectral Index will go up if patient is feeling pain.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>General Anesthesia</condition>
  <arm_group>
    <arm_group_label>sevoflurane with remifentanil</arm_group_label>
    <description>patients receive standardized sevoflurane with different concentrations of remifentanil</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tetanic stimulation</intervention_name>
    <description>Using a standard muscle relaxometer to generate tetanic stimulation</description>
    <arm_group_label>sevoflurane with remifentanil</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled for elective surgery in general anesthesia&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18- 65 years&#xD;
&#xD;
          -  ASA physical status I or II&#xD;
&#xD;
          -  Elective surgery in general anesthesia planned&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of CNS-active medication or abuse of alcohol&#xD;
&#xD;
          -  Presents of any neuromuscular or neurologic disease&#xD;
&#xD;
          -  History of cardiac arrhythmia&#xD;
&#xD;
          -  Pregnancy or using pacemaker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lina Yang</last_name>
    <phone>18611635556</phone>
    <email>Thoth_safin@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Chao Yang Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lina Yang</last_name>
      <phone>18611635556</phone>
      <email>Thoth_safin@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 1, 2021</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Chao Yang Hospital</investigator_affiliation>
    <investigator_full_name>Changwei Wei</investigator_full_name>
    <investigator_title>Deputy chief physician</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

